{"name":"VANDRIA","slug":"vandria","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VNA-318","genericName":"VNA-318","slug":"vna-318","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"VNA-318","genericName":"VNA-318","slug":"vna-318","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNOEdSOXEyRHJqQlJoT0dpZFRrTFNqQ3V6Q2FOZUp6UUdJNVB5YTg2NUJGbDEwNjNZT04zNDVJckk0cG1aZ3RRLXRMaDgtSnUwNEsxZVQyNE5Cc1AwamcyMFpBZm5PX3k0VzNENWFRcHoyUC1LemNvZFZIdUE0d2dJd2NibWozYnFySGVyUU5iSkdFVDZuVVVqNXBhaWI?oc=5","date":"2025-12-05","type":"trial","source":"PMLiVE","summary":"Vandria announces positive phase 1 data for Alzheimer’s treatment - PMLiVE","headline":"Vandria announces positive phase 1 data for Alzheimer’s treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBUYTNVZ0NtTlh2Z3lpdEZoVUpsM01GRnN4b3NMcWkyXzlnS1FIdXIxWkpobXFFSmpqY3NFTVh0eDlrUnBoZUZsejdPaWNYY0JJbkN3?oc=5","date":"2025-12-02","type":"trial","source":"FirstWord Pharma","summary":"Vandria seeks series B funding to advance Alzheimer's candidate into Phase II - FirstWord Pharma","headline":"Vandria seeks series B funding to advance Alzheimer's candidate into Phase II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBXYTUzOVl3ejJrSV8zSmhmV3hzQWtidEhYQktrUS1US29ERmtfclU1UF9yUXRJaFNxa3JOY3hyOVhZRUxSaEJYRVlSYkZON0JGY192UXJ2QnV4YUJ6S05yN0NZNC1GQVpkaC1lWGVoQjF5Q2M?oc=5","date":"2025-12-02","type":"trial","source":"labiotech.eu","summary":"Vandria reports VNA-318’s first-in-human data in Alzheimer’s - labiotech.eu","headline":"Vandria reports VNA-318’s first-in-human data in Alzheimer’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxON3JYU1Q4dU9NZkpBV1lXS19sY0Y2UC12VnFpWkRRdUFpMndtc3dOaG43N0tETk5EUzFDajcyNFNFelRId0VfT3ZBLWc0ZFJ0VTVkYmdUWmcyUllLZnU0TFJyUThodXJ5SE1nME4yaHRsb21WemxOMlQyaFFtbWRKbEI4bGlSanh4?oc=5","date":"2025-01-07","type":"trial","source":"Greater Geneva Bern area","summary":"Vandria begins clinical trials for Alzheimer’s drug VNA-318 - Greater Geneva Bern area","headline":"Vandria begins clinical trials for Alzheimer’s drug VNA-318","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBkTXBRV3MyalN4M1g5LVU5eGFNbkxOM1pfcndoc2NnZ2Z3Nnk0V0x6cVJHVWtYZFhMR1AydEdvMzhpZEJPQ2R5NWZNTGlUQTJOaDRBSmtwSnZNQWpPS0dGS2EwVm5qS1RYTXNqYkVEOU5yMW1qVE5udQ?oc=5","date":"2024-10-02","type":"pipeline","source":"PharmTech.com","summary":"European Biotech Targeting Anti-ageing - PharmTech.com","headline":"European Biotech Targeting Anti-ageing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5RTFpIdW5OR1dJbTZCZ1Itd29jeTRZZXpobE5GOFh2MTJtRVN6MFBadFFsSzhrazRTbFhKa29uMDM5MnpsQzNPTUw2QmpOQUJMX2VLZHhKaGp0Ym04MG9GZ2VMY1BZVkMyOGotekkyVlJxRDNoRkE?oc=5","date":"2024-09-19","type":"pipeline","source":"labiotech.eu","summary":"Mitochondrial disease treatments: is a breakthrough on the horizon? - labiotech.eu","headline":"Mitochondrial disease treatments: is a breakthrough on the horizon?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNOE44clpiVnN2cWhXb2hJTmlPazZvamwxcEh2bldjeXpoLTZsamlQMThYaDNybjhWTWdBSXRWUEw5bkd4dVdpcDQxSjBZZTJ6UEdaQkpxRnI3WFNxMVZoMl8zTWZPRmNJU2ZtVnBiaTdiWHBMYmYyQ0QybnlIeE83VkFnTkNQbGlPeWJMRTVtZ014Yjl3Wl9XdFJ1Ul8zeVRYQm13UQ?oc=5","date":"2024-08-21","type":"pipeline","source":"tech.eu","summary":"Vandria raises $30.7M Series A for mitochondrial therapeutics development - tech.eu","headline":"Vandria raises $30.7M Series A for mitochondrial therapeutics development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNcWwyM1k3WURDX2ozbnZsOGtWY2VOSUFPU242QmpYM2s1REtWTHdUOHBsRmJRYWljaV9OWWZYZmN0b0hHTzlqR1lWaWtPM09SaG9XcGJldXU1eEVGQUtIV1RJZWR5dXlHRzBXd2xxTzFTUmo4OUIxUDlhVjVvZTkxdlJ5czhGMTBDcTFfTFktWQ?oc=5","date":"2023-12-15","type":"pipeline","source":"startupticker.ch","summary":"Vandria raises USD 20.6M and emerges from stealth - startupticker.ch","headline":"Vandria raises USD 20.6M and emerges from stealth","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}